# Juan José García Sánchez

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/juan-jose-garcia-sanchez/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,089 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 20 |
| i10-index | 31 |
| Last Known Institution | AstraZeneca (Switzerland) |
| OpenAlex ID | https://openalex.org/A5027643677 |
| ORCID iD | 0000-0001-6546-7769 |
| Works | 166 |

## Researcher papers

- [Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial](https://scholariq.org/papers/bedtime-hypertension-treatment-improves-cardiovascular-risk-reduction-the-hygia/)
- [Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme](https://scholariq.org/papers/global-economic-burden-associated-with-chronic-kidney-disease-a-pragmatic-review/)
- [Burden of Chronic Kidney Disease by KDIGO Categories of Glomerular Filtration Rate and Albuminuria: A Systematic Review](https://scholariq.org/papers/burden-of-chronic-kidney-disease-by-kdigo-categories-of-glomerular-filtration/)
- [Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for prevention](https://scholariq.org/papers/asleep-blood-pressure-significant-prognostic-marker-of-vascular-risk-and/)
- [An analog front-end enables electrical impedance spectroscopy system on-chip for biomedical applications](https://scholariq.org/papers/an-analog-front-end-enables-electrical-impedance-spectroscopy-system-on-chip-for/)
- [Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review](https://scholariq.org/papers/costs-and-healthcare-resource-use-associated-with-risk-of-cardiovascular/)
- [Projecting the economic burden of chronic kidney disease at the patient level (Inside CKD): a microsimulation modelling study](https://scholariq.org/papers/projecting-the-economic-burden-of-chronic-kidney-disease-at-the-patient-level/)
- [Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease](https://scholariq.org/papers/cost-effectiveness-of-dapagliflozin-as-a-treatment-for-chronic-kidney-disease/)
- [Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: a systematic literature review](https://scholariq.org/papers/health-related-quality-of-life-utility-weights-for-economic-evaluation-through/)
- [Treatment-Time Regimen of Hypertension Medications Significantly Affects Ambulatory Blood Pressure and Clinical Characteristics of Patients With Resistant Hypertension](https://scholariq.org/papers/treatment-time-regimen-of-hypertension-medications-significantly-affects/)
- [PaCE CKD: A Multinational Survey of Financial Burden and Work Productivity in Patients with Chronic Kidney Disease and Caregivers](https://scholariq.org/papers/pace-ckd-a-multinational-survey-of-financial-burden-and-work-productivity-in/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Researcher university

- [AstraZeneca (Switzerland)](https://scholariq.org/institutions/astrazeneca-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.